Radiation timing after breast reconstruction: shorter vs standard schedule
Part of Cancer, Skin clinical trials.
This Phase 3 trial compares two radiation treatment schedules after mastectomy in people who had breast reconstruction. It aims to see which schedule works better and is easier to tolerate for preventing cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female (or able to join studies for female breast cancer patients) and age 19 or older
- You had a mastectomy for invasive breast cancer
- You had breast reconstruction after surgery, such as a tissue expander, or you are already planning reconstruction with an appropriate method
- Your cancer stage is IIIA or lower, but not T4 and not N3, and you need regular “adjuvant” radiation after surgery
- Your general functioning is good enough (ECOG score 0–2, meaning you can do most daily activities)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter radiation plan to a standard longer plan after mastectomy for people considered high risk. It may help reduce treatment time while still trying to prevent breast-cancer recurrence.
This trial compares standard radiation therapy to a shorter course (hypofractionated) for women who have had a mastectomy with implant reconstruction. The goal is to see if the shorter schedule works as well while possibly reducing side effects for the reconstructed breast.
This trial is testing a shorter, higher-dose radiation schedule (hypofractionation) for women who have had a mastectomy and immediate breast reconstruction with implants. The goal is to see if this approach works as well as standard radiation while possibly being more convenient and causing fewer side effects.
This trial studies a radiation schedule given after breast cancer surgery when your breast was rebuilt right away with a prosthesis (implant or similar). It aims to see whether this “hypofractionated” (fewer, larger treatment sessions) radiation approach is appropriate for patients who need additional (adjuvant) radiation to reduce recurrence risk.
This trial compares two ways of giving radiation to the breast/chest wall and nearby lymph nodes after breast surgery: a standard schedule versus a shorter “hypofractionated” schedule. It uses proton therapy and may help reduce treatment time while still controlling the cancer.
This Phase 3 trial tests whether a shorter, more focused radiation treatment to the regional lymph nodes works as well as the current standard approach for certain breast cancers. It may help patients by potentially improving treatment efficiency while keeping cancer control effective.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.